Abstract |
Conventional DNA vaccine strategies usually employ a regimen of immunizations at 2-week or longer intervals to induce effective memory cell-dependent immune responses. Clinical cancer treatment requires a faster immunization strategy to contend with tumor progression. In this study, a novel fast immunization strategy was established, wherein a DNA vaccine was intramuscularly administered on days 0, 2, and 5 in a murine lung cancer model. Effector cells peaked 7 to 10 days after the last vaccination. Compared with traditional 2-week-interval immunization strategies, antigen-specific cytolysis and INF-γ secretion were significantly enhanced under the fast vaccination approach. As a result, the rapidly administered DNA vaccine elicited stronger and more prompt antitumor effects. The probable underlying mechanism of fast immunization was the accumulation of CD8+ CD11c+ antigen-presenting cells at the injection site, which enhanced subsequent antigen presentation. In conclusion, the fast DNA vaccination strategy shortened vaccination time to 5 days and elicited a stronger antitumor immune response.
|
Authors | Chenlu Liu, Xianling Cong, Yuqian Wang, Qianqian Guo, Yu Xie, Fei Geng, Jie Guo, Ling Dong, Yi Zhou, Hui Wu, Bin Yu, Jiaxin Wu, Haihong Zhang, Xianghui Yu, Wei Kong |
Journal | Frontiers in oncology
(Front Oncol)
Vol. 11
Pg. 752444
( 2021)
ISSN: 2234-943X [Print] Switzerland |
PMID | 34950581
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 Liu, Cong, Wang, Guo, Xie, Geng, Guo, Dong, Zhou, Wu, Yu, Wu, Zhang, Yu and Kong. |